GenSight Biologics confirms the success of its IPO by exercising 88.9% of the over-allotment option

August 11, 2016

Archives

2023 (7)
2022 (15)
2021 (41)
2020 (32)
2019 (9)
2018 (21)
2017 (22)
2016 (18)

Categories

Events (3)
News (78)
Press releases (84)

RECENT POSTS

Chronolife and Infiniwell join forces to deliver end-to-end remote health monitoring services

March 22, 2023

Prophesee named in Best of MWC 2023 Awards by Android Authority

February 28, 2023

Prophesee Announces Collaboration with Qualcomm to Optimize Neuromorphic Vision Technologies For the Next Generation of Smartphones, Unlocking a New Image Quality Paradigm for Photography and Video

February 27, 2023

Prophesee named to La French Tech 120

February 20, 2023

http://gensight-biologics.com/index.php?mact=News1,cntnt01,detail,0&cntnt01item_id=12&cntnt01returnid=37

Tags:

EN